touchONCOLOGY.com hosts the expert content from peer-reviewed, free-to-access journals – EU Oncolo
This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations. The information posted on this channel is intended for use by licensed Healthcare Professionals (HCPs).
🚀 Can’t make ? No worries! 🚀
Secure your spot in our exclusive conference hub and get on-demand access to all the action! Dive into expert-led discussions, catch up on hot topics, and stay ahead with the latest trends in oncology care.
👉 Sign up now: https://touchoncology.com/your-free-10-minutes-at-a-time-medical-education/
Don’t miss out—experience the best from with one simple click!
ESMO - European Society for Medical Oncology # BreastCancer
🌟 Get ready for !
Join from September 13 - 17 for an exceptional event featuring the latest scientific content, dynamic learning sessions, and invaluable networking opportunities with leading HCPs from around the globe.
Don't miss out—register now and be part of the global community!
https://touchoncology.com/your-free-10-minutes-at-a-time-medical-education/
ESMO - European Society for Medical Oncology
🎧Introducing our new podcast: Visionary Voices - Insights from healthcare experts 🎙️
We are excited to announce the launch of Visionary Voices, a podcast offering invaluable perspectives for professionals across the healthcare industry.
Tune in to:
🎤 Game-changing innovations: discover how the latest developments in medical education are transforming clinical practice, with insights from leading experts in the field.
🎤 Healthcare icons: learn how prominent experts have shaped clinical practice and inspired the next generation of professionals.
🎤 Enhancing patient care: find out how medical societies and leading experts are collaborating with the aim of improving patient outcomes.
Visionary Voices expands our content variety, ensuring we offer educational resources that cater to all learning preferences.
👉 Subscribe to Visionary Voices here: https://visionaryvoicestmm.podbean.com/
🔊 Catch our first episode featuring Dr Diana Isaacs on The Future of Diabetes Management: https://www.touchendocrinology.com/podcast/the-diabetes-tech-revolution-how-closed-loop-systems-are-transforming-care/
Exciting news! Our COO, David Noble, was recently invited by Touch’s Head of Content, Nicola Cartridge, to join an insightful discussion with Katie King, PhD. Katie and her team at BioOrbit are pushing the boundaries of pharmaceutical innovation by exploring the production of drugs in space—an idea that may seem futuristic but is becoming a near-term reality. This breakthrough holds immense potential for the healthcare industry, offering transformative benefits. Don’t just take our word for it; hear directly from Katie about their incredible work!
🎧 Listen now: https://touchoncology.com/podcast/space-medicine-can-microgravity-transform-pharmaceutical-manufacturing/
🚀 Counting down to ! 🚀
We’re excited for the ESMO 2024 Congress from September 13 - 17, 2024. Don’t miss out—register now for exclusive access to our conference hub and dive into the latest on-demand content.
👉 Register today: https://touchoncology.com/your-free-10-minutes-at-a-time-medical-education/
Be at the forefront of oncology research and innovation with touchONCOLOGY!
ESMO - European Society for Medical Oncology # BreastCancer
In case you missed it...
In this insightful interview, Prof. Hans Hammers discusses how prognostic markers and clinical data are used within the MDT to tailor care for patients across all stages of RCC, from early-stage to advanced and metastatic.
Don't miss these valuable insights! https://touchoncologyime.org/personalizing-care-multidisciplinary-team-renal-cell-carcinoma/
Or
Register now to stay informed: https://touchoncology.com/your-free-10-minutes-at-a-time-medical-education/
This activity is funded by an independent medical education grant from MSD. This activity is jointly provided by USF Health and touchIME.
Revisited...
Join us for an insightful discussion with leading experts, Ms. Nikolina Dodlek and Prof. Sherko Kümmel, on how nurses can best support patients with breast cancer treated with HER2-directed ADCs.
Watch now: https://touchoncologyime.org/knowledge-for-nurses-adc-updates-in-breast-cancer/?noPopup
Or
Register now to stay informed: https://touchoncology.com/your-free-10-minutes-at-a-time-medical-education/
This activity is funded by an independent medical education grant from Daiichi Sankyo Europe GmbH and AstraZeneca. This activity is provided by touchIME. touchIME is an EBAC® accredited provider.
Revisited...
Join us for an insightful session where a medical oncologist and a pathologist address key questions on HER2 in NSCLC.
They will explore the various types of HER2 alterations in NSCLC, their impact on prognosis and treatment, and the best approaches to testing for HER2 alterations. Plus, get the latest clinical trial data on approved and emerging HER2-targeted therapies.
Don't miss this opportunity to stay informed and enhance your patient care!
Learn more: https://touchoncologyime.org/her2_nsclc_testing_and_targeted_therapies/
Or register now to stay informed: https://touchoncology.com/your-free-10-minutes-at-a-time-medical-education/
This activity is funded by an independent medical education grant from AstraZeneca.
This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
September is ?
Throughout September, and raise awareness to the paediatric oncology community.
Stay tuned for updates! 💛🎗️
SIOP Europe, the European Society for Paediatric Oncology - SIOPE
September is almost here! 🌟 Did you know it's ?
That's why, at SIOPE, we hold the meaningful campaign all month long. Throughout September, we and dedicate special events to raise awareness and bring the paediatric oncology community closer than ever.
Exciting events and initiatives await - mark your calendars and stay tuned for updates! 💛🎗️
Have a look at our Campaign toolkit to learn more about our initiatives this year and how can you help to share the message far and wide.
🔗 https://shorturl.at/bLpOi
Revisited...
Listen to expert insights on systemic mastocytosis! 🌟
Join Prof. Dr Vito Sabato, Dr Sigurd Broesby-Olsen and Prof. Prithviraj Bose, as they discuss diagnosis, current and emerging treatments, and multidisciplinary care strategies. Enhance your knowledge and improve patient outcomes.
Watch here: https://touchoncologyime.org/mdt-insights-systemic-mastocytosis
Or
Register now to stay informed: https://touchoncology.com/your-free-10-minutes-at-a-time-medical-education/
This activity is funded by an independent medical education grant from Blueprint Medicines. This activity is jointly provided by USF Health and touchIME.
Revisited....
The wait is over, our new websites are LIVE! 🚀
Announcing a brand new collaboration with our expert faculty! We're thrilled to share that our new websites are officially LIVE.
We’ve partnered with world-renowned faculty to re-imagine our websites. Come and explore an enhanced educational experience designed to optimise your time and elevate professional growth, with the objective of improving patient outcomes. 💡
Here’s what you can expect, in the words of Dr Magdi El-Omar, (Consultant Interventional Cardiologist) who is one of our world-renowned faculty members:
"I am highly impressed with the newly designed Touch websites. It is much easier to locate the articles, videos, and learning activities most relevant to me using the efficient filter function. Additionally, I can stay informed with conference highlights, CME opportunities, and access a comprehensive journal archive. Registration is straightforward to start receiving personalised content recommendations directly to my inbox"
Embark on a journey of professional growth now!
https://linktr.ee/touchmedicalmedia
,
Have you seen our latest video?
Knowledge for nurses: ADC updates in breast cancer
Watch now: https://youtu.be/0ciBpFDnFAA
In this insightful interview, Prof. Hans Hammers discusses how prognostic markers and clinical data are used within the MDT to tailor care for patients across all stages of RCC, from early-stage to advanced and metastatic.
Don't miss these valuable insights! https://touchoncologyime.org/personalizing-care-multidisciplinary-team-renal-cell-carcinoma/
Or
Register now to stay informed: https://touchoncology.com/your-free-10-minutes-at-a-time-medical-education/
This activity is funded by an independent medical education grant from MSD. This activity is jointly provided by USF Health and touchIME.
🌟 The Colorectal Cancer Alliance is proud to present Project Cure CRC—their initiative to drive cutting-edge innovations in colorectal cancer care. Together, we can discover better treatments and move closer to a cure. 💪
👉 Click here to learn more: https://touchoncology.com/insight/project-cure-crc-pushes-for-cutting-edge-innovations-in-colorectal-cancer-care/
Join us in the fight against colorectal cancer!
Colorectal Cancer Alliance
Have you listened to our latest ?
Multidisciplinary insights: Navigating the challenges of systemic mastocytosis diagnosis and management
Listen now: https://touchpodcast.podbean.com/e/touchpanel-discussion-for-touchoncology-multidisciplinary-insights-navigating-the-challenges-of-systemic-mastocytosis-diagnosis-and-management/
Have you listened to our latest ?
Knowledge for nurses ADC updates in breast cancer
Listen now: https://touchpodcast.podbean.com/e/knowledge-for-nurses-adc-updates-in-breast-cancer/
In case you missed it...
The wait is over, our new websites are LIVE! 🚀
Announcing a brand new collaboration with our expert faculty! We're thrilled to share that our new websites are officially LIVE.
We’ve partnered with world-renowned faculty to re-imagine our websites. Come and explore an enhanced educational experience designed to optimise your time and elevate professional growth, with the objective of improving patient outcomes. 💡
Here’s what you can expect, in the words of Dr Magdi El-Omar, (Consultant Interventional Cardiologist) who is one of our world-renowned faculty members:
"I am highly impressed with the newly designed Touch websites. It is much easier to locate the articles, videos, and learning activities most relevant to me using the efficient filter function. Additionally, I can stay informed with conference highlights, CME opportunities, and access a comprehensive journal archive. Registration is straightforward to start receiving personalised content recommendations directly to my inbox"
Embark on a journey of professional growth now!
https://linktr.ee/touchmedicalmedia
,
Revisited...
Join Prof. Heather Wakelee, a leading expert in non-small cell lung cancer (NSCLC), as she delves into the use of immunotherapy for early-stage, resectable NSCLC.
In this activity, she reviews pivotal clinical trials and recent data from ASCO 2024, highlighting their implications for clinical practice. Don't miss this insightful discussion!
Find out more here: https://touchoncologyime.org/io-early-stage-nsclc/
Or
Register now to stay informed: https://touchoncology.com/your-free-10-minutes-at-a-time-medical-education/
This activity is funded by an independent medical education grant from Merck & Co., Inc. This activity is jointly provided by USF Health and touchIME.
Take advantage of the chance to attend at a discounted rate! Register by 22 August to secure your spot and save. Join us for an inspiring event in geriatric oncology! https://loom.ly/-5tvm6U
Have you listened to our latest ?
Decoding HER2 in NSCLC: Advances in biomarker testing and targeted therapies
Listen now: https://touchpodcast.podbean.com/e/decoding-her2-in-nsclc-advances-in-biomarker-testing-and-targeted-therapies/
In case you missed it...
Listen to expert insights on systemic mastocytosis! 🌟
Join Prof. Dr Vito Sabato, Dr Sigurd Broesby-Olsen and Prof. Prithviraj Bose, as they discuss diagnosis, current and emerging treatments, and multidisciplinary care strategies. Enhance your knowledge and improve patient outcomes.
Watch here: https://touchoncologyime.org/mdt-insights-systemic-mastocytosis
Or
Register now to stay informed: https://touchoncology.com/your-free-10-minutes-at-a-time-medical-education/
This activity is funded by an independent medical education grant from Blueprint Medicines. This activity is jointly provided by USF Health and touchIME.
In case you missed it...
Join us for an insightful discussion with leading experts, Ms. Nikolina Dodlek and Prof. Sherko Kümmel, on how nurses can best support patients with breast cancer treated with HER2-directed ADCs.
Watch now: https://touchoncologyime.org/knowledge-for-nurses-adc-updates-in-breast-cancer/?noPopup
Or
Register now to stay informed: https://touchoncology.com/your-free-10-minutes-at-a-time-medical-education/
This activity is funded by an independent medical education grant from Daiichi Sankyo Europe GmbH and AstraZeneca. This activity is provided by touchIME. touchIME is an EBAC® accredited provider.
📢 Join leading oncologist Dr Dana Chase as she explores the role of HER2 as a pan tumour biomarker and its implications for treatment planning across different cancer types.
Discover how HER2-tumour agnostic therapies are reshaping cancer care.
🎥 Watch now: https://touchoncologyime.org/touchfocus_her2-as-a-pan-tumour-biomarker/
Or
Register to stay informed: https://touchoncology.com/your-free-10-minutes-at-a-time-medical-education/
This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
Dr Dana Chase
Have you seen our latest video?
Immunotherapy for early-stage, resectable NSCLC: From clinical trial data to guidelines
Watch now: https://youtu.be/wNLI5Z90KwM
The wait is over, our new websites are LIVE! 🚀
Announcing a brand new collaboration with our expert faculty! We're thrilled to share that our new websites are officially LIVE.
We’ve partnered with world-renowned faculty to re-imagine our websites. Come and explore an enhanced educational experience designed to optimise your time and elevate professional growth, with the objective of improving patient outcomes. 💡
Here’s what you can expect, in the words of Dr Magdi El-Omar, (Consultant Interventional Cardiologist) who is one of our world-renowned faculty members:
"I am highly impressed with the newly designed Touch websites. It is much easier to locate the articles, videos, and learning activities most relevant to me using the efficient filter function. Additionally, I can stay informed with conference highlights, CME opportunities, and access a comprehensive journal archive. Registration is straightforward to start receiving personalised content recommendations directly to my inbox"
Embark on a journey of professional growth now!
https://linktr.ee/touchmedicalmedia
,
In this activity, three leading experts in haematological malignancies discuss the latest evidence and clinical implications of newly approved treatments for relapsed/refractory follicular lymphoma. They emphasize the importance of shared decision-making in selecting treatments, particularly bispecific antibody and CAR T-cell therapies, and key considerations for treatment sequencing.
Watch here: https://touchoncologyime.org/evolving-treatment-paradigm-relapsed-refractory-follicular-lymphoma/
Or
Register now to stay informed: https://touchoncology.com/your-free-10-minutes-at-a-time-medical-education/
In case you missed it...
Join us for an insightful session where a medical oncologist and a pathologist address key questions on HER2 in NSCLC.
They will explore the various types of HER2 alterations in NSCLC, their impact on prognosis and treatment, and the best approaches to testing for HER2 alterations. Plus, get the latest clinical trial data on approved and emerging HER2-targeted therapies.
Don't miss this opportunity to stay informed and enhance your patient care!
Learn more: https://touchoncologyime.org/her2_nsclc_testing_and_targeted_therapies/
Or register now to stay informed: https://touchoncology.com/your-free-10-minutes-at-a-time-medical-education/
This activity is funded by an independent medical education grant from AstraZeneca.
This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
📢 Join us as we count down the hours to the launch of our new websites!
📆 Countdown to launch: 24 hours ⏳
Get ready for a groundbreaking educational experience. Our new websites, developed in collaboration with world-renowned faculty, are tailored to maximise your efficiency, foster your professional development, and ultimately improve patient outcomes. 💡
🌟 What to Expect:
👉Save your progress for all videos
👉Keep track of your CME credits
👉Add personalisation learning notes
👉Receive updates from course leaders and expert faculty
👉Be the first to hear about new and exciting interactive learning opportunities
Register now to see how we are driving positive change in the medical education industry with the expertise of leading faculty.💡🔗https://touchoncology.com/your-free-10-minutes-at-a-time-medical-education/
,
📢 Join us as we count down the hours to the launch of our new websites!
📆 Countdown to launch: 72 hours ⏳
Get ready for a groundbreaking educational experience. Our new websites, developed in collaboration with world-renowned faculty, are tailored to maximise your efficiency, foster your professional development, and ultimately improve patient outcomes. 💡
🌟 What to Expect:
👉Save your progress for all videos
👉Keep track of your CME credits
👉Add personalisation learning notes
👉Receive updates from course leaders and expert faculty
👉Be the first to hear about new and exciting interactive learning opportunities
Register now to see how we are driving positive change in the medical education industry with the expertise of leading faculty.💡🔗https://touchoncology.com/your-free-10-minutes-at-a-time-medical-education/
,
Curious about what your peers think on HER2 in NSCLC? Join our educational activity where real-time questions within the video ensure you won't miss a beat!
Discover what other HCPs think about advances in biomarker testing and targeted therapies. Engage in live polling integrated seamlessly into this activity.
Be part of the experience, learn together: https://touchoncologyime.org/her2_nsclc_testing_and_targeted_therapies/
Be the first to know and let us send you an email when Touch Oncology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to Touch Oncology:
🚀 The countdown to the launch of our new websites has begun! 🚀 Get ready for a transformative educational experience developed in collaboration with world-renowned faculty. Our new websites are designed to optimise your time, enhance professional growth, and ultimately improve patient outcomes. 💡 Our key features allow you to save your video progress, track CME credits, add personalised learning notes, and receive updates from course leaders and expert faculty. Be the first to hear about exciting new interactive learning opportunities! Register now to see how we are driving positive change in the medical education industry with the expertise of leading faculty.💡🔗https://touchoncology.com/your-free-10-minutes-at-a-time-medical-education/ #MedEd #MedComms #NextGenIME #NextGenMedComms #NextGenWeb #DigitalRevolution #InnovationUnleashed #StayTuned
🚀 The countdown to the launch of our new websites has begun! 🚀 Get ready for a transformative educational experience developed in collaboration with world-renowned faculty. Our new websites are designed to optimise your time, enhance professional growth, and ultimately improve patient outcomes. 💡 Our key features allow you to save your video progress, track CME credits, add personalised learning notes, and receive updates from course leaders and expert faculty. Be the first to hear about exciting new interactive learning opportunities! Register now to see how we are driving positive change in the medical education industry with the expertise of leading faculty.💡🔗https://touchoncology.com/your-free-10-minutes-at-a-time-medical-education/ #MedEd #MedComms #NextGenIME #NextGenMedComms #NextGenWeb #DigitalRevolution #InnovationUnleashed #StayTuned
touchONCOLOGY is really pleased to be working with our new partner the European Association of Nuclear Medicine (EANM). "This is the largest non-profit medical organisation dedicated to nuclear medicine in Europe and we hope to assist with EANM's aim to continue meeting the needs of the Nuclear Medicine community for the years to come" said Caroline Markham, Head of Strategic Partnerships | Touch Medical Media Ready for groundbreaking advancements in healthcare! Visit: https://www.touchmedicalmedia.com/news/new-partnership-with-eanm/ #EANM24 EANM
Exciting News! We are thrilled to announce a groundbreaking collaboration between touchONCOLOGY and the prestigious European Association of Nuclear Medicine (EANM)! As the largest non-profit medical organization dedicated to nuclear medicine in Europe, EANM stands at the forefront of innovation and excellence in healthcare. "We are thrilled to embark on this groundbreaking collaboration with EANM," said Caroline Markham, Head of Strategic Partnerships | Touch Medical Media. "EANM's reputation for excellence aligns seamlessly with our commitment to providing unparalleled insights and resources in the field of oncology." Ready for groundbreaking advancements in healthcare! Visit: https://www.touchmedicalmedia.com/news/new-partnership-with-eanm/ #EANM24 EANM
touchONCOLOGY is really pleased to be working with our new partner the European Association of Nuclear Medicine (EANM). "This is the largest non-profit medical organisation dedicated to nuclear medicine in Europe and we hope to assist with EANM's aim to continue meeting the needs of the Nuclear Medicine community for the years to come" said Caroline Markham, Head of Strategic Partnerships | Touch Medical Media Ready for groundbreaking advancements in healthcare! Visit: https://www.touchmedicalmedia.com/news/new-partnership-with-eanm/ #EANM24 EANM
Exciting News! We are thrilled to announce a groundbreaking collaboration between touchONCOLOGY and the prestigious European Association of Nuclear Medicine (EANM)! As the largest non-profit medical organization dedicated to nuclear medicine in Europe, EANM stands at the forefront of innovation and excellence in healthcare. "We are thrilled to embark on this groundbreaking collaboration with EANM," said Caroline Markham, Head of Strategic Partnerships | Touch Medical Media. EANM's reputation for excellence aligns seamlessly with our commitment to providing unparalleled insights and resources in the field of oncology." Ready for groundbreaking advancements in healthcare! Visit: https://www.touchmedicalmedia.com/news/new-partnership-with-eanm/ #EANM24 EANM
touchONCOLOGY has been delighted to support the ground-breaking Cancer Prevention Across Europe campaign (PrEvCan) - aimed at reducing the burden of #cancer with a series of videos. The PrEvCan campaign was initiated and led by the European Oncology Nursing Society (EONS) with the European Society for Medical Oncology (ESMO). See what Dr Lena Sharp had to say about the support touchONCOLOGY provided. Learn more: https://touchoncology.com/?s=prevCan #PrEvCan #CANCERCODE European Oncology Nursing Society
Collaboration with the best is the key to success! We are hugely grateful to be partnered with over 160 medical societies worldwide, covering hundreds of disease areas. For almost twenty years, we have been building unprecedented relationships that continue to grow and expand. As a result, more HCPs and their patients benefit as our cutting-edge medical education is amplified to a national, regional, and global audience. We look forward to many more years of collaboration, growth, and making a positive impact on medical education worldwide. Here’s what Mike Morrissey had to say about working with Touch! #Oncology #Cancer #MedEd #EuropeanCancerSummit
Collaboration with the best is the key to success! We are hugely grateful to be partnered with over 160 medical societies worldwide, covering hundreds of disease areas. For almost twenty years, we have been building unprecedented relationships that continue to grow and expand. As a result, more HCPs and their patients benefit as our cutting-edge medical education is amplified to a national, regional, and global audience. We look forward to many more years of collaboration, growth, and making a positive impact on medical education worldwide. Here’s what Mike Morrissey had to say about working with Touch! #Oncology #Cancer #MedEd #EuropeanCancerSummit
touchONCOLOGY has been delighted to support the ground-breaking Cancer Prevention Across Europe campaign (PrEvCan) - aimed at reducing the burden of #cancer with a series of videos. The PrEvCan campaign was initiated and led by the European Oncology Nursing Society (EONS) with the European Society for Medical Oncology (ESMO). See what Dr Lena Sharp had to say about the support touchONCOLOGY provided. Learn more: https://touchoncology.com/?s=prevCan European Oncology Nursing Society #PrEvCan #CANCERCODE
Collaboration with the best is the key to success! We are hugely grateful to be partnered with over 160 medical societies worldwide, covering hundreds of disease areas. For almost twenty years, we have been building unprecedented relationships that continue to grow and expand. As a result, more HCPs and their patients benefit as our cutting-edge medical education is amplified to a national, regional, and global audience. We look forward to many more years of collaboration, growth, and making a positive impact on medical education worldwide. Here’s what Mike Morrissey had to say about working with Touch! #Oncology #Cancer #MedEd #EuropeanCancerSummit
Collaboration with the best is the key to success! We are hugely grateful to be partnered with over 150 medical societies worldwide, covering hundreds of disease areas. For almost twenty years, we have been building unprecedented relationships that continue to grow and expand. As a result, more HCPs and their patients benefit as our cutting-edge medical education is amplified to a national, regional, and global audience. We look forward to many more years of collaboration, growth, and making a positive impact on medical education worldwide. Here’s what Mike Morrissey had to say about working with Touch! #Oncology #Cancer #MedEd #EuropeanCancerSummit
Collaboration with the best is the key to success! We are hugely grateful to be partnered with over 150 medical societies worldwide, covering hundreds of disease areas. For almost twenty years, we have been building unprecedented relationships that continue to grow and expand. As a result, more HCPs and their patients benefit as our cutting-edge medical education is amplified to a national, regional, and global audience. We look forward to many more years of collaboration, growth, and making a positive impact on medical education worldwide. Here’s what Mike Morrissey had to say about working with Touch! #Oncology #Cancer #MedEd #EuropeanCancerSummit
touchONCOLOGY has been delighted to support the ground-breaking Cancer Prevention Across Europe campaign (PrEvCan) - aimed at reducing the burden of #cancer with a series of videos. The PrEvCan campaign was initiated and led by the European Oncology Nursing Society (EONS) with the European Society for Medical Oncology (ESMO). See what Dr Lena Sharp had to say about the support touchONCOLOGY provided. Learn more: https://touchoncology.com/?s=prevCan #PrEvCan #CANCERCODE European Oncology Nursing Society
Prof. Susanne Saussele, Prof. Massimo Breccia and Prof. Valentín García Gutiérrez consider unmet needs in CML and how new and emerging treatments may help address them. Watch now: https://bit.ly/3XP7Iyl -------- This activity is funded by an independent medical education grant from Novartis and is provided by touchIME. #Leukaemia #Haematology #HaematologicalMalignancies #CML #Oncology
Happy New Year! We’d like to raise a glass to all our supporters, editorial boards, Editors-in-Chief, medical societies, expert faculty and patient advocates… Here’s to another year of creating outstanding touchONCOLOGY education for clinicians worldwide!
In the spirit of the festive season, we want to say a special “thank you” to all the supporters, editorial boards, Editors-in-Chief, medical societies, expert faculty and patient advocates who helped make 2022 such a success. Here’s to you – and lots more to come in 2023!
Watch Prof. Axel Merseburger, Dr Bradley McGregor and Prof. Andrea Necchi summarize and interpret the latest data from the ESMO Congress 2022 on immunotherapies and targeted treatments for bladder cancer. This activity was filmed during the ESMO Congress 2022 (Paris, 9–13 September 2022). Watch now: https://bit.ly/3SW4ffm #ESMO22 #Oncology #ESMOCongress22 #BladderCancer #MedEd #Healthcare #UrothelialCancer
Watch Prof. Axel Merseburger, Dr Bradley McGregor and Prof. Andrea Necchi summarize and interpret the latest data from the ESMO Congress 2022 on immunotherapies and targeted treatments for bladder cancer. This activity was filmed during the ESMO Congress 2022 (Paris, 9–13 September 2022). Watch now: https://bit.ly/3SW4ffm #ESMO22 #Oncology #ESMOCongress22 #BladderCancer #MedEd #Healthcare #UrothelialCancer
Hi St.Gallen International Breast Cancer Conference we created this learning activity which might be of interest to you and your members. We worked with Dr Marleen Kok and Prof. Peter Schmid. What do you think? https://bit.ly/3fJ1HlT
Want your business to be the top-listed Media Company?
The information posted on this channel is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis or treatment recommendations.
touchONCOLOGY.com is an independent source of peer-reviewed content from our biannual journals – European Oncology & Haematology and Oncology & Hematology Review (US). Free to access, it is designed to support busy physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity. Concise and balanced articles authored by leading voices, are complemented by carefully curated video and podcasts.
